Virtus ETF Advisers LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 245 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$262,688
-22.9%
12,605
-11.5%
0.16%
-20.8%
Q2 2023$340,928
-7.2%
14,235
-27.1%
0.20%0.0%
Q1 2023$367,366
+20.4%
19,520
+1.8%
0.20%
+27.0%
Q4 2022$305,234
+28.8%
19,173
+32.3%
0.16%
+69.1%
Q3 2022$237,000
+17.9%
14,493
+1.5%
0.09%
+25.3%
Q2 2022$201,000
-48.7%
14,280
-11.7%
0.08%
-57.1%
Q1 2022$392,000
+4.0%
16,1720.0%0.18%
+23.2%
Q4 2021$377,000
+35.1%
16,172
-3.7%
0.14%
+15.4%
Q3 2021$279,000
-37.6%
16,785
-8.4%
0.12%
-33.2%
Q2 2021$447,000
+44.2%
18,330
+52.7%
0.18%
+40.5%
Q1 2021$310,000
-50.3%
12,004
+2.8%
0.13%
-49.4%
Q4 2020$624,000
+18.6%
11,675
-8.4%
0.26%
-6.2%
Q3 2020$526,000
-7.1%
12,748
+9.2%
0.28%
+3.0%
Q2 2020$566,000
+0.9%
11,674
-12.1%
0.27%
+16.0%
Q1 2020$561,000
-8.9%
13,276
-7.8%
0.23%
+128.7%
Q4 2019$616,000
-40.1%
14,396
-49.6%
0.10%
-51.2%
Q3 2019$1,028,000
+15.2%
28,563
-14.4%
0.21%
+10.1%
Q2 2019$892,000
+76.6%
33,367
+110.1%
0.19%
-23.0%
Q3 2016$505,000
+12.2%
15,878
+14.4%
0.24%
-26.9%
Q2 2016$450,000
+118.4%
13,877
+88.6%
0.33%
+17.6%
Q1 2016$206,000
-26.2%
7,357
-5.8%
0.28%
-62.9%
Q4 2015$279,0007,8140.77%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders